The latest trading day saw Boston Scientific (BSX) settling at $76.85, representing a +1.45% change from its previous close.
Boston Scientific (BSX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Alliance Wealth Advisors LLC UT increased its position in Boston Scientific Corporation (NYSE: BSX) by 207.7% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 16,560 shares of the medical equipment provider's stock after purchasing an additional 11,178 shares during the period. Alliance Wealth Advisors LLC
| Health Care Equipment & Supplies Industry | Healthcare Sector | Michael F. Mahoney CEO | XDUS Exchange | US1011371077 ISIN |
| US Country | 53,000 Employees | - Last Dividend | 6 Nov 2003 Last Split | 18 May 1992 IPO Date |
Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used in a variety of interventional medical specialties. Having begun its operations in 1979, the company has grown to serve a diverse range of medical needs through its two primary segments: MedSurg and Cardiovascular. With its headquarters in Marlborough, Massachusetts, Boston Scientific is committed to improving patient health by providing cutting-edge solutions that address complex medical conditions and enhance the quality of life for patients worldwide.